Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Clara Moelle"'
Autor:
Moritz Bewarder, Maximilian Kiefer, Helene Will, Kathrin Olesch, Clara Moelle, Stephan Stilgenbauer, Konstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Joerg Thomas Bittenbring, Natalie Fadle, Evi Regitz, Lea Kaschek, Markus Hoth, Frank Neumann, Klaus-Dieter Preuss, Michael Pfreundschuh, Lorenz Thurner
Publikováno v:
HemaSphere, Vol 5, Iss 8, p e620 (2021)
Mantle cell lymphoma (MCL) accounts for 5%–10% of all lymphomas. The disease’s genetic hallmark is the t(11; 14)(q13; q32) translocation. In younger patients, the first-line treatment is chemoimmunotherapy followed by autologous stem cell transpl
Externí odkaz:
https://doaj.org/article/5324ddacc5804349809eddbf248c6384
Autor:
Moritz Bewarder, Maximilian Kiefer, Clara Moelle, Lisa Goerens, Stephan Stilgenbauer, Konstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Natalie Fadle, Evi Regitz, Frank Neumann, Markus Hoth, Klaus-Dieter Preuss, Michael Pfreundschuh, Lorenz Thurner
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Recently, neurabin-I and SAMD14 have been described as the autoantigenic target of approximately 66% of B-cell receptors (BCRs) of primary central nervous system lymphomas (PCNSL). Neurabin-I and SAMD14 share a highly homologous SAM domain that becom
Externí odkaz:
https://doaj.org/article/18b55799ea4b4f80b3435573908e08d7
Autor:
Stephan Stilgenbauer, Dominic Kaddu-Mulindwa, Moritz Bewarder, Helene Will, Natalie Fadle, Frank Neumann, Maximilian Kiefer, Clara Moelle, Michael Pfreundschuh, Klaus-Dieter Preuss, Konstantinos Christofyllakis, Evi Regitz, Lea Kaschek, Lorenz Thurner, Joerg Thomas Bittenbring, Markus Hoth, Kathrin Olesch
Publikováno v:
HemaSphere
HemaSphere, Vol 5, Iss 8, p e620 (2021)
HemaSphere, Vol 5, Iss 8, p e620 (2021)
Mantle cell lymphoma (MCL) accounts for 5%–10% of all lymphomas. The disease’s genetic hallmark is the t(11; 14)(q13; q32) translocation. In younger patients, the first-line treatment is chemoimmunotherapy followed by autologous stem cell transpl